Sheila Wills BSc BVetMed CertSAM DipECVIM-CA MRCVS, specialist in internal medicine, has joined Wey Referrals, the Surrey-based multi-disciplinary veterinary referral practice.
Professor John Innes, Referral Director at CVS (of which Wey Referrals is a part) said: "We are delighted to welcome Sheila to our specialist team at Wey Referrals. Her experience and knowledge will further strengthen the service we offer and her appointment is another important step in the development of our referral team in the South East. Attracting the highest calibre talent is important to CVS because we want to build a referral team, whose members are not only clinically excellent but who also possess first rate communication and inter-personal skills."
Sheila said: "I am excited to be joining the CVS specialist team and look forward to working with like-minded colleagues who are passionate and dedicated to providing the highest level of patient care and client communication. I am delighted to be able to offer a specialist internal medicine service in both feline and canine medicine and look forward to offering a comprehensive service to CVS clients and expanding the internal medicine service further in the future."
Sheila graduated from the Royal Veterinary College in 1998 and spent five years in small animal practice before undertaking an FAB Residency in Feline Medicine at the University of Bristol.
Shortly after her residency, she was appointed Head of Small Animal Medicine and the Feline Centre at the Animal Health Trust where she was based for two years before moving to a major veterinary laboratory in December 2009. She recently returned to the University of Bristol as a teaching fellow in feline medicine.
Sheila acquired her ECVIM Diploma in Internal Medicine in September 2010 and is a Recognised European Veterinary Specialist in Internal Medicine. She became an RCVS Recognised Specialist in Feline Medicine in March 2012 and enjoys all aspects of feline medicine with a specialist interest in feline renal and ureteric disease. She is a member of the ICC Feline Expert Panel and an editorial board member for the Journal of Feline Medicine and Surgery.
Vetsonic UK has announced the addition to its range of Vetericyn Super 7+, a brand new umbilical cord dry-out solution for use in calves, lambs, piglets, foals, kids and puppies which is designed as an alternative to iodine.
Vetsonic says that because Super 7+ contains no iodine, it won't encourage licking by iodine-deficient mothers, which can cause serious damage to the navel. It is also an ideal alternative for handlers who are prone to iodine allergies.
The company points to a US study conducted by Auburn University in which Super 7 + demonstrated more than double the desiccation efficacy in the first 24 hours when compared to 7% tincture of iodine.
Super 7+ contains a dye for easy identification of treated animals and the company says it is environmental friendly, safe, non-flammable and non-corrosive with no toxic fumes.
Super 7 + is now available through veterinary wholesalers and direct from Vetsonic (UK) Ltd, either in a 500 ml spray bottle (box of 6) or a 3.78 litre bottle for dipping.
For more information, visit www.vetsonic.com
CarefreeCredit, the vet-run company we reported on back in October, has announced that it is working with its 600th practice in offering its interest-free or low-interest credit to clients that find themselves unable to pay for unforeseen veterinary treatment.
Stewart Halperin MRCVS, Managing Director of CarefreeCredit said: “2014 has been an incredibly busy but successful year for us. We’ve increased the take up of our service by over 500%, we have proudly cemented our partnerships within the corporate and buying groups and most importantly, we have become established enough to make a substantial difference to the pets and pet owners who rely on the help our service provides.”
Stewart added: “We know 2015 is going to be an even bigger year for us, with even more practices joining our system and the introduction of dependable and innovative business support services that will continue to save our practices time and money and help them increase sales and reduce debtors. With this in mind, we are introducing a very small monthly charge to cover our increased costs in software, training and office support services.”
From the New Year, practices that join Carefree Credit will be charged a flat rate of £10 per month for the duration of their membership. The £10 monthly fee covers support for FCA applications, unlimited training in-practice or online, use of the CarefreeCredit unique platform, CarefreeCredit office support, and point of sale materials. Practices that sign up before January 1st, will continue their membership without charge until at least January 2016.
For further information, visit: carefreecredit.co.uk or ring 0203 697 8439.
The RCVS has announced that its new Royal Charter, which recognises veterinary nursing as a profession, is due to come into effect early next year once it has been signed by Her Majesty the Queen and received the Great Seal of the Realm.
The Charter, which was approved at a meeting of the Privy Council on 5 November, sets out and clarifies the objects of the RCVS and modernises its regulatory functions.
The Charter will also confirm the role of the College as the regulator of veterinary nurses and give registered veterinary nurses the formal status of associates of the College.
In addition, the Charter will also underpin other activities of the College such as the Practice Standards Scheme.
One of the key changes is that those qualified veterinary nurses who are currently on the List will automatically become registered veterinary nurses. This means that they will be required to abide by the Code of Professional Conduct for Veterinary Nurses, will be held accountable for their actions through the RCVS disciplinary process and will be expected to keep their skills and knowledge up-to-date by undertaking at least 45 hours of continuing professional development (CPD) over a three-year period.
In addition, the Charter will give formal recognition for VN Council to set the standards for professional conduct and education for veterinary nurses.
Kathy Kissick RVN, the current chair of VN Council, said: “A Charter which recognises veterinary nursing as a fully regulated profession is something that many veterinary nurses, as well as the British Veterinary Nursing Association, have been wanting for some time so I commend this development.
“This can only be a good thing for the profession, the industry as a whole and animal welfare because it makes sure that registered veterinary nurses are fully accountable for their professional conduct and are committed to lifelong learning and developing their knowledge and skills.
“Furthermore, the new Royal Charter is a significant step towards attaining formal, statutory protection of title, which would make it an offence for anyone who is not suitably qualified and registered to call themselves a veterinary nurse.”
From next autumn those former listed veterinary nurses who have become registered veterinary nurses will be expected to confirm that they are undertaking CPD and will also need to disclose any criminal convictions, cautions or adverse findings when they renew their registration.
A detailed set of frequently asked questions for listed veterinary nurses who will become registered veterinary nurses once the Charter is implemented can be found at www.rcvs.org.uk/rvn.
Although the date for signing and sealing the Charter has not yet been confirmed, once it comes into effect the College will be contacting all listed veterinary nurses by letter to outline the changes as well as putting an announcement on www.rcvs.org.uk.
Lintbells Veterinary has announced the launch of Yurelieve, a feline urinary health supplement containing multiple glycosaminoglycans, L-tryptophan and EFAs.
Andrew Connolly, Product Manager at Lintbells Veterinary said: "Yurelieve supports a condition which is not only frustrating to treat, but can also be distressing for the cat and their owners. The launch of Yurelieve will enable veterinary surgeons to offer their clients the most comprehensive feline urinary health support available."
Yurelieve contains Green Lipped Mussel, which Lintbells says provides a unique combination of Omega 3 fatty acids (EPA, DHA and ETA) to aid the cat’s own natural anti-inflammatory process. In addition, the product contains multiple GAGs and N-acetyl D-glucosamine to support the bladder lining, and L-tryptophan which the company says is proven to decrease stress related behaviours in cats.
To mark the launch of the new supplement, Lintbells is running a Facebook competition in which vets and nurses are invited to share photos of their cats, with a statement that captures their unique personality.
Andrew continued: “When cats are affected by a urinary condition, it takes their independence and personality away from them, so we wanted to celebrate the importance of allowing cats to be their natural charismatic selves with a photo competition starring everyone’s feline friends.”
To enter the competition, post a photo of a beloved cat with a caption that captures their unique personality, starting with ‘I believe…’ to the Lintbells Vet Facebook page (www.facebook.com/lintbellsvet). The best will win a Pampurrrr Spa Day for 2.
Yurelieve is available from your veterinary wholesaler now, in packs of 30 capsules.
For more information on Yurelieve speak to your Lintbells Business Development Executive or call 01462 790886.
Elanco Animal Health has launched Vulketan, a POM-V sterile topical gel developed to encourage the healing of equine wounds.
Vulketan contains ketanserin - a serotonin-S2 antagonist.2 Elanco says that although serotonin is more widely known as a neurotransmitter in the brain, it is also found in platelets and released during platelet aggregation where it can have negative effects on wound healing.4, 7
Managing equine wounds is an everyday occurrence in equine practice1 and can be difficult and time-consuming, with many potential complications such as infection or the development of proud flesh which could delay healing or lead to reduced functionality. Repeated dressings can be a hassle for owners, and if used inappropriately can lead to their own complications.5
Elanco representative Kirsty Prudon said: "Vulketan gel is easy to use and is designed to be applied to undressed wounds, although it has been demonstrated that wounds may be dressed, if required, without affecting Vulketan's efficacy2,6.
Elanco also points to studies which it says demonstrate that Vulketan has been shown in client owned horses to be highly effective in preventing the formation of hypergranulation tissue and may facilitate the control of secondary infections.2,3,6. In addition, owners expressed satisfaction with Vulketan in over 90% of cases.6
Practising equine vet Linda Belton MRCVS said: "Vulketan is easy to use, well tolerated by horses and produces an excellent end cosmetic result and return to function. With the reduction in the need for dressings and proud flesh control Vulketan has proven to be an advantageous product which owners value."
Vulketan is suitable for use in all horses including pregnant and lactating mares. It is supplied in 75 gram tubes and should be applied twice daily.
For more information, contact your Elanco territory manager call Elanco on 01256 353131.
References
Heath Vets, a Cardiff-based veterinary group, has announced that is has become the first veterinary group in Wales to appoint designated customer care personnel, enabling it to take on and beat the corporates at customer service.
Leanne Kiddie was appointed Customer Care Manager, tasked with ensuring the group delivers excellent customer service across its four sites, after the veterinary group identified customer service as their key driver to retaining customers, attracting new customers and sustaining growth.
Gavin Hill-John (pictured right with Leanne), Operations Director at Heath Vets said: "We want to put our customers at the forefront of our service. The traditional veterinary practice model was based around territory; you had one vet practice in an area and local people used it. They weren’t challenged on customer service as we are today. Having Leanne as our dedicated Customer Care Manager will help us set Heath Vets apart from other practices. Whilst we may not be able to compete with the buying power of some national chains, we can certainly beat them at customer service."
Heath Vets says it is now developing its engagement with customers regarding future plans; using their comments and feedback to shape the practice.
Gavin added: "We are aiming to deliver a level of engagement with our customers that no other vet practice has seen before. We’re hosting cheese and wine functions where customers can come in, enjoy our festive hospitality, and speak with the staff about their pet’s issues. We not only want to work with our customers, but we want to get to know them."
Gavin says he believes Heath Vets can challenge all competitors when it comes to customer service: "My vision for the role is that across all four sites we should be delivering outstanding customer service, consistently. To achieve that aim, everybody needs to be highly skilled, trained, motivated and engaged. For us, it’s about recognising that we have a hugely impressive team that are focussed on delivering high quality customer service. National chains have investors and shareholders to please; we have our customers."
Dechra Veterinary Products has announced that it is to relaunch Fuciderm Gel, the topical skin product used to treat surface pyoderma in dogs, as Isaderm.
Isaderm contains fusidic acid, which Dechra says is highly effective against the bacteria Staphylococcus pseudintermedius, and the steroid betamethasone, which is both an anti-inflammatory and anti-pruritic.
Available as a white translucent gel in 15 g and 30 g tubes, Isaderm is a topical treatment which can be applied directly and stays on the affected area - the base of Isaderm is a carbomer gel which maintains contact on skin and wet lesions.
Dechra Dermatology Brand Manager Roger Brown said: "Fuciderm is one of our most popular products. As part of an international Dechra rebranding programme the name will now be Isaderm® but veterinary professionals can be assured that the only thing about the product that has changed is the name.
"This treatment was the subject of a multi-centre UK trial* comparing treatment of surface pyoderma with the gel or systemic therapy, and the gel product was shown to be as effective as systemic therapy."
For further information, visit www.dechra.co.uk
The RCVS has announced that it is to host an open day on Monday 15 December for those members of the veterinary and veterinary nursing professions who are interested in joining the College’s Preliminary Investigation Committee (PIC), Disciplinary Committee (DC) or Veterinary Nurse Preliminary Investigation Committee (VN PIC).
In January 2015 the College will be looking to recruit veterinary members for PIC and DC following a legislative reform order last year to reconstitute them separately from RCVS Council. This means that the committees must be made up of veterinary and lay members who are not on Council and members will be appointed on the advice of an independent selection committee.
The RCVS will be seeking to recruit four veterinary surgeons for DC as well as three veterinary surgeons for PIC. At the same time the College will be recruiting two registered veterinary nurses and a veterinary surgeon for VN PIC. Applications are particularly sought from practising or recently retired clinicians.
The Open Day (at Belgravia House from 9.30am to 4pm) will provide the opportunity for those who are interested in applying to hear from current members of each committee about what being a committee member is really like and the type of cases dealt with. Recruitment consultants will also be on hand to explain the hiring process and attendees will have the opportunity to put questions to Gordon Hockey, RCVS Registrar.
Those who are interested in attending the Open Day should contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk or 020 7202 0761 to register an interest or request an agenda.
MWI Veterinary Supply Inc, the parent company of Centaur Services, has acquired practice management software company Vetspace in order to offer practices wholesaler services that are better integrated with their practice management system.
Vetspace, formerly Jupiter Systems, has been developing and providing server and cloud-based practice management software for veterinary practices since 1989. There are over 1,000 installations of Vetspace's software solutions in the UK.
The recent acquisition by MWI Veterinary Supply sees Vetspace joining a group of companies including Centaur Services and Securos, a manufacturer and supplier of veterinary orthopedic solutions.
Centaur Services' core business is the daily delivery of products required by UK veterinary practices. MWI says Vetspace customers will now benefit from an enhanced level of customer service, innovative product development, technological investment and an opportunity for greater integration between their practice management software and wholesaler - all backed by the experience and investment of a global parent company.
Centaur Services customers may continue to use any other practice management system, whilst Vetspace customers may continue to work with other wholesalers. Brian Topper, Managing Director of Centaur Services said: "We're very pleased to be able to offer our customers throughout the UK the opportunity to further enhance and streamline their practices by integrating their practice management system and wholesaler solution. Our focus is on delivering a high quality service that's accurate and reliable and we believe that aligning our offer with that of Vetspace will have major benefits for the future of both ours and our customers' businesses."
Nader Pour of Vetspace added: "Having been at the forefront of practice management software for the past 25 years we are delighted to be joining the MWI Veterinary Supply group and working with the likes of Centaur Services to further develop the benefits we're able to offer our customers for the next 25 years and beyond."
Picture shows, left to right: Brian Topper, Centaur Services, Nader Pour, Vetspace and Jim Cleary, CEO of MWI.
The RCVS has published new guidance for veterinary surgeons and veterinary nurses on the use of social media and online forums, such as those on VetSurgeon.org and VetNurse.co.uk.
The guidance sets out the professional standards expected of veterinary professionals, as well as providing advice on good practice, how to protect privacy, maintaining client confidentiality and dealing with adverse comments from clients.
The guidance has been developed by the Standards Committee, partly in response to demands from the profession and partly in light of recent decisions by the courts and other regulatory bodies which demonstrate that professionals can be at risk of legal or disciplinary action where their online conduct is unprofessional or inappropriate.
Laura McClintock, RCVS Advisory Solicitor said: "Whilst social media is likely to form part of everyday life for veterinary professionals, who are just as free as anyone else to take advantage of the personal and professional benefits that it can offer, its use is not without risk, so vets and vet nurses should be mindful of the consequences that can arise from its misuse."
The new guidance explains that vets and vet nurses are expected to behave professionally online, whether publishing material as themselves or anonymously. The College highlights the fact that demonstrably inappropriate behaviour on social media may place registration at risk, as the professional standards expected online are no different to those in the 'real world'.
Laura added: "Understanding and applying our new guidance should help vets and nurses to meet their professional responsibilities and reduce the risks of receiving complaints from clients or others, as well as potential civil actions for defamation."
The new guidance can be found on the RCVS website at: www.rcvs.org.uk/socialmedia
Ed's comment: The new guidance seems like common sense to me. A couple of things stand out as useful reminders, though. The first is to anonymise details of the cases you discuss on vetsurgeon.org, or get your clients' prior permission to discuss their animal in a professional forum. The other is the fact that being disparaging about a colleague online is as much of a breach of the Code of Professional Conduct as if you do it offline. So don't!
Ceva has announced the launch of Zodon®, a flavoured clindamycin for dogs and cats.
Zodon is the only veterinary licensed flavoured clindamycin available in the UK.
Zodon is indicated for the treatment of infected wounds and abscesses in cats and dogs and oral cavity/dental infections caused by or associated with clindamycin-sensitive species of Staphylococcus spp, Streptococcus spp in dogs.
Rob Mclintock, Business unit manager for Ceva said: "Zodon is an exciting new product for Ceva, it is the first clindamycin on the market to offer flavoured presentations designed to help deal with compliance issues and help improve treatment success."
In a palatability study 98.3% of dogs took Zodon chicken flavoured tablets spontaneously. Ceva says the oral solution for cats and small dogs also offers easier administration with grilled meat flavouring and a graduated syringe.
Adelaide Ellerington, product manager for Ceva Animal Health said: "Zodon complements our existing antibiotic range perfectly. The whole range is designed specifically for veterinary use allowing veterinary surgeons to dose more accurately and improve patient compliance by offering flavoured tablets and solutions."
You can preorder Zodon now from Ceva - telephone 01494 781510 or email: cevauk@ceva.com - alternatively Zodon will be available from wholesalers at the start of next week.
The RCVS has published Fitness to Practise - A Guide for UK Veterinary Schools and Veterinary Students, a guide for veterinary students which aims to introduce them to the concept of fitness to practise and help prepare them for professional life.
The guide was developed by an RCVS working party in conjunction with the UK's seven veterinary schools that currently offer an RCVS-approved veterinary degree. It has also received approval from the Veterinary Schools Council, a new body which represents the interests of the country's veterinary schools.
The guide is split into two parts: the first part provides guidance for veterinary schools on how to recognise and address fitness to practise concerns; the second part sets out the broad principles of fitness to practise that students should follow and which veterinary schools should uphold.
Laura McClintock, an Advisory Solicitor from the RCVS Professional Conduct Department, said: "While we don't regulate veterinary students themselves, we hope that this guidance will prepare future vets for the requirements and standards that we expect from members of a regulated profession and for adhering to our Code of Professional Conduct and its supporting guidance.
"The guide also recognises that each university will have its own specific disciplinary guidelines and procedures, but we hope that this will help promote consistency in their fitness to practise regimes.
"Although we expect any adverse findings made in university fitness to practise proceedings to be declared to us upon application to register, we would take into account the fact that a student is not a fully-fledged professional and would therefore make some allowance for any mistakes and poor judgement when considering whether or not they should join the Register."
The guide can be downloaded for free from www.rcvs.org.uk/studentguide
The RCVS is also in the process of forming a working party to produce equivalent guidance for student veterinary nurses.
The RCVS and the BVA have announced the launch of Vet Futures, a jointly funded initiative designed to stimulate discussion about the future of the profession, and help its members prepare for and shape it.
The initiative will draw on the experience and insight of a wide range of individuals and organisations, including veterinary surgeons and nurses, veterinary bodies, farmers, pet owners and other key stakeholders.
The objective is to understand where the provision of veterinary services is currently heading, whether this is in the best interests of the profession, animal owners and the public at large, and what might be done to shape an optimal future for the veterinary team, keeping animal health and welfare at its heart.
In the project's first phase, independent researchers will gather evidence via focus groups, phone interviews and desk-based research, in addition to the gauging of opinion through events, the internet and social media.
This evidence gathering will be followed by an engagement phase, where the profession will be asked for their feedback on initial thoughts; a period of analysis, where a report will be written by the independent researchers; and, finally, there will be an action phase, where key strategic issues will be identified, together with a clear plan for action from the BVA and the RCVS, as well as other organisations and individuals.
Professor Stuart Reid, RCVS President. said: "The RCVS is implementing a programme of reform to make it a first-rate regulator, but how do we also make ours a first-rate profession, that is resilient and agile enough to meet future demands?
"The Vet Futures project will not just be about horizon-scanning, but getting a fix on those issues over the horizon that we may not yet have considered, such as the use of emerging technologies.
"It's an exciting challenge and I am looking forward to members of the veterinary team getting involved so that, together, we can develop an action plan that will deliver a sustainable future for the profession."
John Blackwell, BVA President, said: "It is no secret that the veterinary profession is changing rapidly and that is why the theme for my presidential year is 'driving change and shaping the future'. It is essential that we come together to map out where we want to be as a strong and trusted profession and identify how we can make that happen.
"On such cross-cutting issues it is appropriate that the two leading professional bodies come together to provide joint leadership for the profession, but we are keen to engage as many individuals and stakeholders as possible. It is designed to be a hugely collaborative project and we want to hear voices from across the whole profession and the whole veterinary team."
The project has a dedicated website www.vetfutures.org.uk where the latest events, reports and publications will be found. There will also be a 'topic of the month' for the duration of the project, with controversial opinion-pieces being posted to stimulate debate from within the profession and amongst animal owners and other stakeholders.
Dechra Veterinary Products has launched Sporimune (ciclosporin), licensed for the treatment of chronic manifestations of atopic dermatitis in dogs.
Roger Brown, Senior Brand Manager at Dechra Veterinary Products, said: "Around 20% of all small animal consultations involve skin conditions and canine atopic dermatitis can be challenging to diagnose and manage effectively.
"Although incurable, atopic dermatitis can be managed using a multimodal approach which is likely to include treatments to decrease pruritus as well as allergen identification, avoidance where possible and improving skin and coat hygiene."
Sporimune is a 50 mg/ml oral solution administered by syringe, which is graduated to show both bodyweight and ml. Dechra says it is being introduced to veterinary professionals within the company's Partners in Practice programme which aims to support vets and vet nurses as they diagnose, control and maintain complex dermatological conditions.
Mr Brown added: "It is critical that owners are fully involved and educated about their pet's condition for dogs to be treated effectively. So we have also developed support materials around the use of Sporimune for practices, including client information leaflets and a video on how to use the dosing syringe."
Sporimune is now available from veterinary wholesalers. For further information visit www.dechra.co.uk/sporimune.
The Society of Practising Veterinary Surgeons (SPVS) has published its 2014 Salaries Survey which showed that the gender pay gap has closed from 15% last year to 10.8% this.
However, the association notes that this is still slightly higher than the gap reported for all professions in the UK, so there remains work to be done.
The survey, which is the largest of its kind and drew responses from 1,878 vets, nurses, practice managers and receptionists also found that:
Peter Brown, SPVS Treasurer and author of the report comments: "The SPVS Salaries Survey is intended as a benchmark to give some indication of what is being paid as the 'going rate' rather than to advise on what employees should be paid. Having said that, we would urge all veterinary practices to continue working to ensure that equal rates of pay are given for positions of equal status. Although the gender gap has closed up, it is still too big."
The annual SPVS Salaries Survey is free of charge to SPVS members and costs £150 for non-members. For more information, call 01926 410454 or visit www.spvs.org.uk.
Vétoquinol (maker of Propalin) has announced the launch of a new canine urinary incontinence support website for pet owners.
canineui.co.uk contains information about the causes, diagnostic methods and treatment options for canine urinary incontinence. It also includes tips for living with a dog with the condition.
To help spread the word to owners and raise the awareness that this new resource is available, Vétoquinol is offering posters for your practice, together with business cards displaying the website address.
To obtain your copy call the Vétoquinol head office on 01280 825497 and quote 'Canine UI Poster'.
The RCVS has published a summary of the goings on at its 6 November meeting.
Amongst other things, Council agreed to continue to display postnominals in the Register, undertake a consultation on whether members should be able to use the courtesy title 'doctor' and make amendments to the College's current registration regulations.
In addition,
More information about these decisions can be found in the latest edition of RCVS News, copies of which have been sent to all veterinary surgeons and listed/registered veterinary nurses.
The full papers for the Council meeting can be found on the RCVS website at www.rcvs.org.uk/about-us/rcvs-council/council-meetings
The Emergent Disease Foundation, One Health Initiative, Worldwide Veterinary Service, and UNISON have collaborated to launch Exotic pets: Reducing the of risk of human infection, a new leaflet which explains the hygiene measures that keepers of exotic pets should take.
The organisations say that they hope veterinary clinics, pet shops, medical centres, local authorities and schools will distribute the free leaflet which is also available to download.
The Emergent Disease Foundation says the advice contained in the leaflet is taken from an independent scientific paper entitled 'A review of captive exotic animal-linked zoonoses' published in the Journal of Environmental Health Research.
The leaflet takes the line that it is inadvisable to keep exotic animals as pets, but for those who already have them, recommended measures include: thorough hand-washing with antibacterial soap and alcohol-based gels after handing or feeding an exotic pet; being careful not to touch hair, clothes (including pockets), door handles and other items immediately after handling exotic pets; closely supervising children so that they do not put their mouths close to the animal; and keeping animals, cages and equipment away from kitchens.
Clifford Warwick of the Emergent Disease Foundation, a charity focused on animal-to-human infections, said: "The modern world enables all too easy acquisition of exotic animals into the home. The pet trade in general, with its high turnover and diversity of species available, offers a speed-dating reservoir for bugs from far corners of the globe. My own advice is simple - avoiding exposure to bugs from exotic pets in the home is difficult and best avoided by not keeping them in the first place."
Dr. Bruce Kaplan of the One Health Initiative, which focuses on the connection between health and the environment, said: "As a former U.S. Centers for Disease Control and Prevention (CDC) trained epidemiologist, a retired private practice veterinarian and a public health and humanitarian minded 'One Health' activist for nearly 50 years, I wholeheartedly oppose private ownership of exotic pets due to the known scientific health and safety risks for people and animals. It is a dangerous, irresponsible and irrational practice."
Owen Evans of the Worldwide Veterinary Service, a charity that provides a veterinary resource to animal welfare organisations worldwide, said:"We work on a day-to-day basis with animal health issues, so we are very mindful of how animals and people can share pathogens. Avoiding transmission is best served by minimising risks, which is what this new brochure aims to achieve."
The RCVS has announced that it is carrying out an audit of continuing professional development (CPD) for vets in order to monitor compliance and gauge what type of activities they are engaging in.
Under the RCVS Code of Professional Conduct, introduced in 2012, veterinary surgeons are expected to undertake 105 hours of CPD over a rolling three-year period in order to demonstrate that they are maintaining and advancing their knowledge and skills.
Nearly 5,000 vets - made up of three cohorts - have been asked to share their CPD records. The first cohort comprises 4,425 UK-practising vets who registered before 1 April 2012 but who did not confirm their CPD compliance upon renewing their registration this year. The second cohort comprises a random sample of 400 vets who did confirm their compliance upon renewing their registration this year. The third cohort comprises 84 vets who graduated before 2012 but have not yet completed their post-graduation Professional Development Phase.
Christine Warman, RCVS Head of Education, said: "Since it is coming up to three years since we introduced the Code we thought that now is a good time to take stock of the proportion of veterinary surgeons that are fulfilling the requirement and how they are doing so.
"It is also a good time to remind members of the profession of the importance of CPD and that it is not just a tick-box exercise but vital for everyday practice. Engaging in CPD is a personal obligation for all veterinary surgeons and demonstrates to both the profession and public that they are continually advancing their capability and competence.
"This year we will be providing some guidance on what constitutes CPD and how to undertake it to those who are non-compliant. However, from 2015, we may also refer those who repeatedly fail to comply, or respond to requests to submit their records, to our Professional Conduct Department for further investigation."
Vets who have been selected to take part in the audit will have received letters in early November and will have until Monday 1 December to respond. They can do so by either allowing the RCVS to view their online Professional Development Record (PDR) profile or by submitting their paper CPD record by post or by sending the College a scanned copy by email.
For further advice and to submit a CPD record by email, contact cpd@rcvs.org.uk. Those who have not yet registered for the PDR can do so by visiting www.rcvs-pdr.org.uk
MSD Animal Health (Merck in the US and Canada), has launched Finadyne (flunixin), the NSAID for cattle, as a pour on.
According to the company, Finadyne Transdermal is the world's first non-parasiticide cattle product to be made available as a pour-on.
Dr. Martin Behr, technical manager at MSD Animal Health said: “Finadyne Transdermal is uniquely designed for rapid absorption into the bloodstream and its antipyretic effect has been demonstrated as early as two hours after treatment. This is because innovative penetration enhancers are included in the formulation to improve the absorption of the active ingredient flunixin through the skin.”
The new product comes in pre-calibrated packaging and uses a bottle designed for easy application along an animal’s back.
Dr. Behr added: “It’s much simpler for farmers to treat cattle in this way – as opposed to administering an injection, which can also mean needle-site lesions that can reduce the value of a carcass or compromise hide quality.
“The time taken to handle and treat animals will be much reduced with a transdermal NSAID. There will also be a saving on syringes and needles.”
Finadyne Transdermal (POM-V) is available now from veterinary wholesalers. Further information is available from the MSD Animal Health veterinary support group on 01908 685685.
Norbrook has announced the launch of Spotinor Deltamethrin spot-on, a new product which kills a wide range of external parasites that can have economically damaging effects on cattle, sheep and lambs.
The product is effective against lice and flies on cattle, ticks, lice, keds and established blowfly strike on sheep, and lice and ticks on lambs. It is available in 250ml and 500ml squeeze neck dispensing packs as well as a 1 litre and 2.5 litre backpack with dosing gun. The dose is 10ml for cattle, 5ml for sheep and 2.5ml for lambs (under 10kg/1 month of age).
Spotinor has a zero milk withhold time.
Edward Haughey, Director of Norbrook GB, said: "As Britain's leading veterinary pharmaceutical company, Norbrook is committed to providing British farmers and vets with the products and services they need to manage animal health effectively. Spotinor is the first generic to market, which displays the same benefits as the pioneer product. We are delighted to launch Spotinor, which gives livestock producers a greater choice of safe and sound solutions for the control of external parasites."
For more information, contact your Norbrook representative, telephone +44 (0) 1536 741 147 or email: enquiries@norbrook.co.uk
Invicta Animal Health has launched an enhanced version of the ChroMyco Duo dermatophyte test.
The tests use a new round plate with an improved lid design. In addition, the plates are wider and deeper providing 25% more culture medium.
According to the company, the dual plate test with Dermatophyte Test Media (DTM) on one side and an Enhanced Sporulation Agar (ESA) on the other greatly reduces the risk of false positive results.
The test is performed by veterinary staff taking a pluck of fur or skin scrape from the lesion and inoculating both sides. After three to six days of room temperature incubation, if dermatophytes are present, the DTM will turn red and the ESA will turn blue-green.
Rob Watkins, Managing Director of Invicta, said: "We always listen and respond to customer feedback. The new design plates provide reduced condensation levels and by being easier to inoculate will enhance the usability and hence reliability of the test."
The price remains unchanged at £32.00 for 5 tests, from veterinary wholesalers.
For more information call 01403 791313 or email mail@invictavet.com.
Royal Canin has launched a range of new renal diets to help support cats and dogs with Chronic Kidney Disease (CKD).
According to the company, CKD patients are twice as likely to show signs of anorexia, food intolerance and loss of appetite than non-CKD pets, so the focus with the new diets has been on different aromatic profiles, textures and tastes to provide choice and encourage feeding without compromising the nutritional management of the pets with CKD.
Royal Canin says each of the diets in the new Renal range has been developed with a unique aromatic profile, so that cats and dogs can be attracted to their food bowl even after an episode of food aversion.
The new range also provides two different textures of dry diet for both cats and dogs. In addition to the classic kibbles found in Renal and Renal Special, the new Renal Select diet for cats has a pillow kibble with a thin, crunchy shell and a soft centre for cats who used to love crunching but are beginning to struggle with harder kibbles. The new kibbles for dogs are designed to be easy to rehydrate, providing the taste of a dry diet in a softer, easier to chew format. A new Renal Wet range is also available with a 'loaf' or 'chunks-in-gravy' texture and these can be combined with any dry diet to allow even greater variety of textures.
With CKD causing frequent fluctuations in an animal's sense of taste, Royal Canin has made the feline range available in smaller 500g bags, making it easier for owners to swap between the differing options as their pet's tastes alter.
Royal Canin's Veterinary Marketing Manager, Marianne Lomberg, said: "The efficiency of a renal diet depends upon it being fed on a continuing basis and so our new range provides a complete range of aromatic profiles and textures to keep your CKD patients enjoying every meal without compromising on their nutritional management. Royal Canin has a proven track record of developing innovative diets to help pets, and the new Renal Diets are an exciting new move for us."
Royal Canin is also offering a 'patient compliance guarantee' where vets and their clients can claim their money back if a pet does not like any of the many diet combinations offered by the range.
Virbac has has announced the launch of Buprevet, a buprenorphine-based, injectable solution indicated for the potentiation of sedative effects of centrally-acting agents in dogs and for use in cats and dogs as part of a multimodal approach to analgesia.
Buprevet is presented in a 10 ml multi-dose bottle which can be broached up to 25 times and can be open for up to 28 days.
Sarah Walker MRCVS, Product Manager, said: "Buprenorphine is a potent, high affinity, synthetic opioid agonist which forms a key element of practice anaesthetic protocols and complements our existing anaesthetic range. Its potentiation effects means less sedation is needed in the pre-medication and in the anaesthesia, facilitating smoother recoveries with more comfortable patients."
"Buprenorphine is a tried and trusted solution for analgesia in many practices. Buprevet can be given pre-operatively to allow analgesia during and after surgery. It works effectively as part of a pre-emptive approach to analgesia, alongside products such as Inflacam and Carprox in our NSAIDs range."